Aptyx Expands Footprint With Acquisition of Medical Murray FacilityAptyx Expands Footprint With Acquisition of Medical Murray Facility

Aptyx this week announced the acquisition of the Charlotte, NC, facility of Medical Murray, which develops and produces catheter-based interventional products and transcatheter implants.

The company noted the facility will become an integral part of Aptyx Interventional Systems, fortifying the company’s interventional and implantable expertise with a pool of engineering talent.

Greg Tobin, president and CEO of Aptyx, said the acquisition marks a key step in the company’s growth strategy, strengthening its interventional product capabilities and end-to-end offerings, driving innovation, and delivering greater value to OEM life science customers.

“It is a key element of our original blueprint and just the beginning of our evolution, with much more growth to follow,” he said.

The transaction enhances the Design & Development Center's capabilities, offering advanced manufacturing support for customers and strengthening expertise in catheter-based interventional products and transcatheter solutions, including implantable stents, frames, complex catheters, and delivery systems. It also expands the company’s ISO Class 7 capabilities and adds specialized knowledge in biotextiles, such as ePTFE coverings for stents and frames. 

Aptyx has long been recognized for producing engineered products and for its expertise in mission-critical molding, extrusion, coating solutions, and medical device assembly. 

By joining forces with Medical Murray, Aptyx will now be able to provide a comprehensive manufacturing solution for catheter-based interventional and implantable products.

“We’re committed to conquering technical challenges and delivering on time and cost-efficient products for the structural heart, vascular, neurovascular, and other key end markets,” said Eric Leopold, who served as CTO of Medical Murray and leader of the Charlotte, NC, business. “Joining Aptyx and combining our comprehensive experience in interventional markets provides the rocket fuel for long-term growth.”

After the acquisition, Leopold will join Aptyx as senior vice president. Charlotte team members will become part of Aptyx. Medical Murray will continue to operate separately through its two facilities in the Chicagoland area.

Parker Poe Adams & Bernstein acted as legal counsel and Raymond James as financial advisor to Aptyx and TruArc Partners. Buckley Fine acted as legal counsel and Areida Group as financial advisor to Medical Murray.

“Aptyx Interventional Systems broadens the Aptyx footprint in the high-growth interventional market and adds competitive and high-value manufacturing and design and development capabilities,” said John Pless, co-managing partner, private equity firm TruArc Partners. “Continued investment is planned to further support customers in the life sciences industry, reinforcing Aptyx’s position as a trusted outsource manufacturing partner.”

Headquartered in Tempe, AZ, Aptyx has locations in Torrington, CT; Jaffrey, NH; South Glens Falls, NY; Kent, OH; Miamisburg, OH; North Canton, OH; Sellersville, PA; Eagle Pass, TX; and Oshkosh, WI. It has international locations in Milton, Ontario, Canada; Trenton, Ontario, Canada; Piedras Negras, Mexico; Changzhou, China; and Guangzhou, China. 

The company operates more than 120 injection molding presses, more than 65 dip molding machines, and more than 80 extrusion lines. The organization serves the medical device and life sciences market as well as a number of other key sectors including motion control and facility automation, aerospace and defense, and energy. With integrated, specialized engineering and manufacturing capabilities, Aptyx's solutions range from development through manufacturing, assembly, and packaging.

Formerly known as Molded Devices Inc., the company rebranded itself as Aptyx in October 2023. It had been acquired by TruArc Parners in 2022.  

Aptyx is an exhibitor at MD&M West, being held Feb. 4 to 6, 2025, at the Anaheim Convention Center in Anaheim, CA.